The Properties of Known Drugs. 1. Molecular Frameworks

Guy W. Bemis* and Mark A. Murcko
Vertex Pharmaceuticals, 130 Waverly Street, Cambridge, Massachusetts 02139-4242
J. Med. Chem., 1996, 39 (15), pp 2887–2893
DOI: 10.1021/jm9602928
Publication Date (Web): July 19, 1996
Copyright © 1996 American Chemical Society
*

 To whom correspondence should be addressed. E-mail:  bemis@ vpharm.com.

Abstract

In order to better understand the common features present in drug molecules, we use shape description methods to analyze a database of commercially available drugs and prepare a list of common drug shapes. A useful way of organizing this structural data is to group the atoms of each drug molecule into ring, linker, framework, and side chain atoms. On the basis of the two-dimensional molecular structures (without regard to atom type, hybridization, and bond order), there are 1179 different frameworks among the 5120 compounds analyzed. However, the shapes of half of the drugs in the database are described by the 32 most frequently occurring frameworks. This suggests that the diversity of shapes in the set of known drugs is extremely low. In our second method of analysis, in which atom type, hybridization, and bond order are considered, more diversity is seen; there are 2506 different frameworks among the 5120 compounds in the database, and the most frequently occurring 42 frameworks account for only one-fourth of the drugs. We discuss the possible interpretations of these findings and the way they may be used to guide future drug discovery research.

View: Full Text HTML | Hi-Res PDF

Tools

SciFinder Links

SciFinder subscribers: Click to sign in | Not a SciFinder subscriber? Learn more at www.cas.org

History

  • Published In Issue July 19, 1996
  • Received April 19, 1996

Recommend & Share

Related Content

Other ACS content by these authors: